Abstract

The COVID-19 pandemic is putting unprecedented pressures on healthcare systems globally. Early insights have been made possible by rapid sharing of data from China and Italy. In the UK, we have rapidly mobilised inflammatory bowel disease (IBD) centres in order that preparations can be made to protect our patients and the clinical services they rely on. This is a novel coronavirus; much is unknown as to how it will affect people with IBD. We also lack information about the impact of different immunosuppressive medications. To address this uncertainty, the British Society of Gastroenterology (BSG) COVID-19 IBD Working Group has used the best available data and expert opinion to generate a risk grid that groups patients into highest, moderate and lowest risk categories. This grid allows patients to be instructed to follow the UK government’s advice for shielding, stringent and standard advice regarding social distancing, respectively. Further considerations are given to service provision, medical and surgical therapy, endoscopy, imaging and clinical trials.

Rights

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

Cite as

Kennedy, N., Jones, G., Lamb, C., Appleby, R., Arnott, I., Beattie, R., Bloom, S., Brooks, A., Cooney, R., Dart, R., Edwards, C., Fraser, A., Gaya, D., Ghosh, S., Greveson, K., Hansen, R., Hart, A., Hawthorne, A., Hayee, B., Limdi, J., Murray, C., Parkes, G., Parkes, M., Patel, K., Pollok, R., Powell, N., Probert, C., Raine, T., Sebastian, S., Selinger, C., Smith, P., Stansfield, C., Younge, L., Lindsay, J., Irving, P. & Lees, C. 2020, 'British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic', Gut, 69(6), pp. 984-990. http://dx.doi.org/10.1136/gutjnl-2020-321244

Downloadable citations

Download HTML citationHTML Download BIB citationBIB Download RIS citationRIS
Last updated: 17 June 2022
Was this page helpful?